Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Chances and challenges of retinoid X receptor gamma targeting for regenerative multiple sclerosis treatment.
Changes and variability of proton density and T1 relaxation times in early multiple sclerosis: MRI markers of neuronal damage in the cerebral cortex.
Marijuana Legalization: Impact on Physicians and Public Health.
Alternatives for reducing relapse rate when switching from natalizumab to fingolimod in multiple sclerosis.
Intrinsic third ventricular craniopharyngioma: A case report.
Citrullination of TNF-α by peptidylarginine deiminases reduces its capacity to stimulate the production of inflammatory chemokines.
ASP4058, a Novel Agonist for Sphingosine 1-Phosphate Receptors 1 and 5, Ameliorates Rodent Experimental Autoimmune Encephalomyelitis with a Favorable Safety Profile.
Frequency of Blood-tissue Parasitic Infections in Patients with Multiple Sclerosis, as Compared to their Family Members.
Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.
Research Findings on Overactive Bladder.
Exergaming with additional postural demands improves balance and gait in patients with multiple sclerosis as much as conventional balance training and leads to high adherence to home-based balance training.
Neuropeptide Y protects cerebral cortical neurons by regulating microglial immune function.
The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis.
Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis.
Patient education programme on immunotherapy in multiple sclerosis (PEPIMS): A controlled rater-blinded study.
MUNDUS project: MUltimodal Neuroprosthesis for daily Upper limb Support.
Central adaptation after optic neuritis: Is the whole greater than the sum of its parts?
Impairment and disability in 20 CIDP patients according to disease activity status.
Is MS an inflammatory or primary degenerative disease?
Characterization of Microcirculation in Multiple Sclerosis Lesions by Dynamic Texture Parameter Analysis (DTPA).
Coexistence of Multiple Sclerosis and Ankylosing Spondylitis: Report of Two Cases.
Multiple Sclerosis Outcome Assessments Consortium: Genesis and initial project plan.
Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large series.
Clinical Outcome of 50 Progressive Multiple Sclerosis Patients Treated with Cellular Therapy in Iraq.
The Neurophysiologist Perspective into MS Plasticity.
Pages
« first
‹ previous
…
608
609
610
611
612
613
614
615
616
…
next ›
last »